As of 2025-09-18, the Relative Valuation of Akoya Biosciences Inc (AKYA) is (23.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.29 USD, the upside of Akoya Biosciences Inc based on Relative Valuation is -1944.2%.
The range of the Relative Valuation is (23.73) - (22.88) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.9x - 27.2x | 26.4x |
| Forward P/E multiples | 22.0x - 24.0x | 23.6x |
| Fair Price | (23.73) - (22.88) | (23.79) |
| Upside | -1939.8% - -1873.4% | -1944.2% |
| Date | P/E |
| 2025-07-07 | -1.36 |
| 2025-07-03 | -1.43 |
| 2025-07-02 | -1.42 |
| 2025-07-01 | -1.39 |
| 2025-06-30 | -1.37 |
| 2025-06-27 | -1.30 |
| 2025-06-26 | -1.40 |
| 2025-06-25 | -1.35 |
| 2025-06-24 | -1.31 |
| 2025-06-23 | -1.36 |
| 2025-06-20 | -1.32 |
| 2025-06-18 | -1.37 |
| 2025-06-17 | -1.31 |
| 2025-06-16 | -1.33 |